Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Dr.Been#04.3 - Evidence of Epstein-Barr Virus (EBV) Reaction in Long Haul COVID: Long Story Short with Dr. Been Episode 4, Series 3 of 4

Dr.Been#04.3 - Evidence of Epstein-Barr Virus (EBV) Reaction in Long Haul COVID: Long Story Short with Dr. Been Episode 4, Series 3 of 4

FromFLCCC Alliance


Dr.Been#04.3 - Evidence of Epstein-Barr Virus (EBV) Reaction in Long Haul COVID: Long Story Short with Dr. Been Episode 4, Series 3 of 4

FromFLCCC Alliance

ratings:
Length:
25 minutes
Released:
May 15, 2022
Format:
Podcast episode

Description

The Long Story Short with Dr. Been
Evidence of Epstein Barr Virus Reactivation in Long COVID Patients
Dr. Been reviews a study published on June 17th 2021 that shows that 30% of COVID long-haul patients have EBV reactivation. He reviews the study and the evidence presented.
Original video from Dr. Been posted in August 2021
Reference to the study:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233978/
Other studies supporting the evidence of EBV in COVID long-haul:
https://pubmed.ncbi.nlm.nih.gov/28956548/
https://pubmed.ncbi.nlm.nih.gov/2987786/
https://pubmed.ncbi.nlm.nih.gov/231279/
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
Released:
May 15, 2022
Format:
Podcast episode

Titles in the series (100)

The FLCCC Alliance was organized in March 2020 by a group of highly published, world renowned Critical Care physician/scholars – with the academic support of allied physicians from around the world. The organization’s goal is to research and develop lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness.